279 related articles for article (PubMed ID: 20005417)
1. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
Mawad R; Hsieh A; Damon L
Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417
[TBL] [Abstract][Full Text] [Related]
2. Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation.
Whalen JG; Jukic DM; English JC
J Am Acad Dermatol; 2005 May; 52(5):908-12. PubMed ID: 15858489
[TBL] [Abstract][Full Text] [Related]
3. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
Weinstein A; Dexter D; KuKuruga DL; Philosophe B; Hess J; Klassen D
Transplantation; 2006 Jul; 82(1):127-31. PubMed ID: 16861952
[TBL] [Abstract][Full Text] [Related]
4. The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant.
Post GR; Black JS; Cortes GY; Pollack RB; Wolff DJ; Lazarchick J
Ann Clin Lab Sci; 2011; 41(2):188-92. PubMed ID: 21844579
[TBL] [Abstract][Full Text] [Related]
5. Lung transplantation complicated by graft-versus-host disease and confounded by incidental transfusion-associated macrochimerism.
Pavenski K; Kamel-Reid S; Wei C; Cserti-Gazdewich CM
Transfusion; 2008 Oct; 48(10):2190-6. PubMed ID: 18631170
[TBL] [Abstract][Full Text] [Related]
6. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
7. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
8. Acute graft-versus-host disease after pediatric solid organ transplant.
Yashar S; Wu SS; Binder SW; Cotliar J
J Drugs Dermatol; 2008 May; 7(5):467-9. PubMed ID: 18505140
[TBL] [Abstract][Full Text] [Related]
9. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
10. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
11. [Graft versus host disease after liver transplantation: a report of 3 cases].
Liang TB; Tang XF; Zheng SS; Lu AW; Wang WL; Shen Y; Zhang M; Meng XQ
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):826-9. PubMed ID: 15200885
[TBL] [Abstract][Full Text] [Related]
12. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism.
Pageaux GP; Perrigault PF; Fabre JM; Portales P; Souche B; Dereure O; Eliaou JF; Larrey D; Domergue J; Michel H
Clin Transplant; 1995 Feb; 9(1):65-9. PubMed ID: 7742585
[TBL] [Abstract][Full Text] [Related]
13. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
[TBL] [Abstract][Full Text] [Related]
14. Acute graft versus host disease following living donor liver transplantation: first Korean report.
Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
[TBL] [Abstract][Full Text] [Related]
15. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
16. Late onset of severe graft-versus-host disease following liver transplantation.
Sun B; Zhao C; Xia Y; Li G; Cheng F; Li J; Zhang F; Wang X
Transpl Immunol; 2006 Nov; 16(3-4):250-3. PubMed ID: 17138062
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor.
Gorman TE; Julius CJ; Barth RF; Ng A; Kennedy MS; Prior TW; Allen J; Lasky LC
Am J Clin Pathol; 2000 May; 113(5):732-7. PubMed ID: 10800407
[TBL] [Abstract][Full Text] [Related]
19. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
20. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
